COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Click to access mobile menu
Print
  • Share:
Skip Navigation LinksHome > ODS Programs and Initiatives > NIH CARBON/Botanical Research Centers Program: Prior Awards > NIH CARBON Program: Research Center for Botanical Immunomodulators: 2005 - 2010

NIH CARBON Program:
Research Center for Botanical Immunomodulators: 2005 - 2010

Results in NIHReporterexternal link disclaimer

Principal Investigators: Barrie R. Cassileth, Ph.D. and Philip O. Livingston, M.D.
Institution: Memorial Sloan-Kettering Cancer Center, New York, NY
Partners: Weill Medical College of Cornell University, Ithaca, NY; The Rockefeller University, New York, NY; Institute of Chinese Medicine, Chinese University of Hong Kong, Hong Kong.

The thematic focus of this center was botanical immunomodulators relevant to the treatment of cancer and infectious disease. The investigators studied echinacea (Echinacea purpurea), astragalus (Astragalus membranaceus), turmeric (Curcuma longa), maitake and selected additional botanicals used in Traditional Medical systems for their immunomodulatory activity.

Research projects included: Botanicals as Adjuvants or Immunomodulators with Vaccines Against Cancer; Modulation of Antibody Based Cancer Immunotherapy by Botanicals; Regulation of Pathogen-Specific Immune Defense by Botanicals; and Development of Biomarkers for Study of Botanical Immunomodulators in Humans. 

 

 Prior CARBON Awards | NIH CARBON Program